TRILC.E — Turk Ilac ve Serum Sanayi AS Cashflow Statement
0.000.00%
Last trade - 00:00- TRY2.55bn
- TRY5.10bn
- TRY4.54bn
Annual cashflow statement for Turk Ilac ve Serum Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 37.1 | -81.7 | 153 | 94.7 | -623 |
| Depreciation | |||||
| Non-Cash Items | 10.5 | 168 | 120 | 634 | 2,050 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -127 | 48 | 95.8 | -1,288 | -875 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -71.7 | 148 | 408 | -490 | 614 |
| Capital Expenditures | -20.6 | -38.4 | -115 | -199 | -256 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.77 | — | — | -10.1 | 108 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -19.8 | -38.4 | -115 | -209 | -148 |
| Financing Cash Flow Items | -27 | -148 | -228 | -698 | -1,567 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 136 | -170 | -372 | 702 | -459 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 44.4 | -60.6 | -79.1 | -1.52 | 4.8 |